Navigation Links
WaferGen Announces Signing of Two Private Placements
Date:5/19/2008

FREMONT, Calif., May 19 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced the signing of two separate private placements. The details of the financings, which have not yet closed, are as follow:

-- WaferGen has agreed to sell shares of the company's common stock and

warrants to certain funds for which Brencourt Advisors is the

investment manager and to certain other existing investors in a private

placement for total proceeds of approximately $3.6 million. Under the

terms of the agreement, WaferGen will sell 1,585,550 shares of common

stock at a price of $2.25 per share, with 40% warrant coverage at an

exercise price of $3.00 per share. The warrants have a five-year term

and standard broad-based weighted-average anti-dilution protection.

The financing is expected to close in the next couple of days.

Proceeds from this financing will be used for general corporate

purposes including the continued advancement of the company's

SmartChip(TM) Real-Time PCR System, as well as the expansion of the

company's global commercialization campaign for its SmartSlide(TM)

Micro-Incubation System.

-- WaferGen has agreed to sell redeemable convertible preferred shares in

the company's wholly owned Malaysian subsidiary, WaferGen Biosystems

(M) Sdn. Bhd., in a private placement to Malaysian Technology

Development Corporation Sdn. Bhd. (MTDC), a leading venture capital and

development firm in Malaysia. Under the terms of the agreement,

WaferGen has agreed to sell 444,444 redeemable convertible preferred

shares in the subsidiary for gross proceeds of $1.0 million. WaferGen

will sell an additional 444,444 redeemable convertible
'/>"/>

SOURCE WaferGen Biosystems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. WaferGen to Present at the Rodman and Renshaw Fifth Annual Global Healthcare Conference
2. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in Germany
3. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in United Kingdom and France
4. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
5. WaferGen Announces Management Team Promotions
6. WaferGen to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
7. WaferGen to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
8. Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
9. CorVel Corporation Announces Earnings Release Webcast
10. Boston Scientific Announces FDA Approval of New Heart Failure Lead
11. Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... YORK , July 7, 2015 ... Biotechnologies - Gene Therapy Market Analysis" report is ... the gene therapy field. Using detailed company data, ... GlobalData provides an in-depth analysis of the current ... market. The report discusses the key factors shaping ...
(Date:7/7/2015)... Richmond, BC (PRWEB) , ... July 07, 2015 ... ... highlighting early HIV detection using INSTI HIV-1/HIV-2 Antibody Test was accepted for presentation ... and Prevention in Vancouver. The results will be presented Wednesday, July 22nd from ...
(Date:7/7/2015)... ... ... uBiome, the leading microbial genomics company, is offering talented researchers with big ... laboratory analysis. The goal is to fast-track a study with the greatest potential to ... dashboard, enabling them to view and compare the results of their study, as well ...
(Date:7/7/2015)... ... July 07, 2015 , ... The ... barriers to innovation in life science R&D, has attracted a number of new ... another top ten pharmaceutical company joining as a Core member, and DNAnexus and ...
Breaking Biology Technology:PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis 2bioLytical to Present Findings of Early HIV Detection 2bioLytical to Present Findings of Early HIV Detection 3uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 2uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 3Pistoia Alliance Continues to Attract New Members 2
... , , , ATLANTA and ... CRY ) an implantable biological medical device and cardiovascular ... BioFoam (R) Surgical Matrix, which received CE mark ... procedure following tumor removal as a supplemental measure to promote hemostasis ...
... , COLUMBIA, Md., Sept. 10 DHA omega-3 innovator ... (Nasdaq: MATK ), announced today it has resolved a ... action for infringement filed in the High Court of Strasbourg, France. ... agreement between Martek and Capsugel France, Capsugel and all of its ...
... AUSTIN, Texas, Sept. 10 , , WHO: Panel ... , WHEN: Tuesday, September 15th , , ... 4th Conference on eDiscovery for Pharma, Biotech & Medical Device Industries , ... TOPIC: Cost-Benefit Analysis of In-house eDiscovery Tools vs. Outsourcing Help , ...
Cached Biology Technology:CryoLife Announces First Clinical Use of BioFoam(R) 2CryoLife Announces First Clinical Use of BioFoam(R) 3CryoLife Announces First Clinical Use of BioFoam(R) 4CryoLife Announces First Clinical Use of BioFoam(R) 5Martek Announces Settlement of Patent Dispute with Capsugel France 2StoredIQ Shares Expertise at IQPC's eDiscovery Pharma, Biotech and Medical Device Conference 2
(Date:6/24/2015)... June 24, 2015 This report provides market ... next six years. It contains an analysis of the ... with their impact from the short, medium, and long ... the industry, market, and technology trends that currently, prevail ... of concerned authorities to efficiently manage the increasing marine ...
(Date:6/24/2015)... June 22, 2015 ... addition of the "Huawei Ascend Mate 7 ... to their offering. Huawei,s technological choice ... opposite direction than Apple,s and Samsung,s one. The ... developed by Fingerprint Cards, a main actor in ...
(Date:6/23/2015)... , June 23, 2015   MedNet ... that supports the entire spectrum of clinical research, ... ™ , the company,s intuitive, flexible ... awarded a Silver 2015 Stevie® Award by the ... Products & Services Website category.  The American Business ...
Breaking Biology News(10 mins):Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... Carbon dioxide (CO2) distinguishes itself as the fastest growing ... regulation of CO2 emissions depends on our ability to ... source of the increase. Until the late ... Hawaii, many questioned whether the industrial revolution and the ...
... new study has identified the first common gene variants ... significant risk factor for heart attack, stroke and kidney ... journal Nature Genetics identifies variants in genes ... also appear to influence blood pressure levels, an association ...
... well as how their brains operate, a study at the ... symposium, "Social Emotion and the Brain," at the annual meeting ... the first to use fMRI scans to study the connections ... brain. Combining fMRI scans with data relevant to social behavior ...
Cached Biology News:Carbon accounting from atmospheric measurements -- the aircraft perspective 2Common gene variants increase risk of hypertension, may lead to new therapies 2Researchers shed new light on connection between brain and loneliness 2Researchers shed new light on connection between brain and loneliness 3
Request Info...
...
... Provide us with target blotted protein ... solution (preferably in water), The N-terminal sequence ... out on samples purified by HPLC or ... PVDF (Polyvinylidene difluoride) membranes using the well ...
albumin from bovine serum (BSA), Texas Red® conjugate...
Biology Products: